Search

Search Constraints

You searched for: Author/Creator Amin, Nikhil

Search Results

3. Dupilumab efficacy in adolescents with uncontrolled, moderate‐to‐severe asthma: LIBERTY ASTHMA QUEST. Issue 8 (10th May 2021)

4. Dupilumab improves health related quality of life: Results from the phase 3 SINUS studies. Issue 7 (1st February 2022)

5. Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Issue 1 (23rd October 2019)

6. Dupilumab improves lung function in patients with uncontrolled, moderate-to-severe asthma. Issue 1 (27th January 2020)

7. Dupilumab in children aged 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 10356 (17th September 2022)

8. Dupilumab in CRSwNP: Responder Analysis Using Clinically Meaningful Efficacy Outcome Thresholds. (24th November 2021)

9. Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases. Issue 7 (26th June 2021)

10. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Issue 10209 (2nd November 2019)